When Should You SELL Your Stocks (8 Reasons to Sell Your Stocks) Click to watch on Youtube.

Bioventus Inc. Stock Forecast

NASDAQ:BVS BUY

$8.66 (3.22%)

Volume: 149.349k

Closed: Aug 10, 2022

Hollow Logo Score: 1.624

Bioventus Inc. Stock Forecast

BUY NASDAQ:BVS
$8.66 (3.22%)

Volume: 149.349k

Closed: Aug 10, 2022

Score Hollow Logo 1.624

BVS Stock Insider Trading NASDAQ:BVS

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 39.043.

In total, the insiders bought 2 373 042 and sold 851 878 BVS shares in the last 100 trades.

INSIDER POWER

39.043

Last 100 transactions
Buy: 2 373 042 | Sell: 851 878 (Shares)
Date Action Amount Person Type
Jun 17, 2022 Buy 16 648 Hawkins William A Restricted Stock Units
Jun 17, 2022 Buy 16 648 Nohra Guy P Restricted Stock Units
Jun 17, 2022 Buy 16 648 Beyer Pat Restricted Stock Units
Jun 17, 2022 Buy 965 Beyer Pat Restricted Stock Units
Jun 17, 2022 Buy 16 648 Stalnecker Susan M Restricted Stock Units
Jun 17, 2022 Buy 16 648 Vizirgianakis Stavros G. Restricted Stock Units
Jun 17, 2022 Buy 965 Vizirgianakis Stavros G. Restricted Stock Units
Jun 17, 2022 Buy 16 648 Neels Guido J Restricted Stock Units
Jun 17, 2022 Buy 16 648 Sutter Martin P Restricted Stock Units
Jun 17, 2022 Buy 16 648 Ladone Mary Kay Restricted Stock Units
Jun 17, 2022 Buy 1 813 Ladone Mary Kay Restricted Stock Units
Jun 17, 2022 Buy 16 648 Mcmurry-heath Michelle Restricted Stock Units
Jun 17, 2022 Buy 385 Mcmurry-heath Michelle Restricted Stock Units
Jun 16, 2022 Buy 965 Beyer Pat Class A common stock
Jun 16, 2022 Buy 965 Vizirgianakis Stavros G. Class A common stock
Jun 16, 2022 Buy 1 813 Ladone Mary Kay Class A common stock
Jun 16, 2022 Buy 385 Mcmurry-heath Michelle Class A common stock
Apr 04, 2022 Sell 37 476 D'adamio Anthony Restricted Stock Units
Apr 04, 2022 Sell 16 016 D'adamio Anthony Class A Common Stock
Apr 04, 2022 Sell 106 485 Nosenzo John Restricted Stock Units
Apr 04, 2022 Sell 65 963 Nosenzo John Class A Common Stock
Apr 04, 2022 Sell 61 476 Pavesio Alessandra Restricted Stock Units
Apr 04, 2022 Sell 32 997 Pavesio Alessandra Class A Common Stock
Apr 04, 2022 Buy 223 200 Singleton Mark Leonard Stock Option (Right to Buy)
Apr 04, 2022 Buy 74 500 Singleton Mark Leonard Restricted Stock Units
Apr 01, 2022 Sell 40 573 Hawkins William A Restricted Stock Units
Apr 01, 2022 Buy 40 573 Hawkins William A Class A Common Stock
Apr 01, 2022 Buy 37 476 D'adamio Anthony Class A Common Stock
Apr 01, 2022 Buy 106 485 Nosenzo John Class A Common Stock
Apr 01, 2022 Sell 2 700 Neels Guido J Restricted Stock Units
INSIDER POWER

39.043

Last 100 transactions
Buy: 2 373 042 | Sell: 851 878 (Shares)

About Bioventus Inc.

Bioventus Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones,... Read more

.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT